Steward Partners Investment Advisory’s Theriva Biologics TOVX Stock Holding History

Steward Partners Investment Advisory’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$3	–	3847
2024 Q2	$3	Hold	1	–	–	﹤0.01%	3603
2024 Q1	$7	Hold	1	–	–	﹤0.01%	3554
2023 Q4	$6	Hold	1	–	–	﹤0.01%	3483
2023 Q3	$8	Hold	1	–	–	﹤0.01%	3370
2023 Q2	$14	Hold	1	–	–	﹤0.01%	3307
2023 Q1	$10	Hold	1	–	–	﹤0.01%	3295
2022 Q4	$6	Hold	1	–	–	﹤0.01%	3347
2022 Q3	$0	Hold	1	–	–	﹤0.01%	3381
2022 Q2	$0	Hold	1	–	–	﹤0.01%	3371
2022 Q1	$0	Hold	1	–	–	﹤0.01%	3380
2021 Q4	$0	Hold	1	–	–	﹤0.01%	3320
2021 Q3	$0	Hold	1	–	–	﹤0.01%	3333
2021 Q2	$0	Hold	1	–	–	﹤0.01%	7396
2021 Q1	$98	Hold	1	–	–	﹤0.01%	3387
2020 Q4	$0	Hold	1	–	–	﹤0.01%	2992
2020 Q3	$0	Hold	1	–	–	﹤0.01%	2850
2020 Q2	$0	Hold	1	–	–	﹤0.01%	2751
2020 Q1	$0	Hold	1	–	–	﹤0.01%	2699
2019 Q4	$0	Hold	1	–	–	﹤0.01%	2745
2019 Q3	$0	Hold	1	–	–	﹤0.01%	2769
2019 Q2	$0	Buy	+1	New	+$144	﹤0.01%	2694
2018 Q4	–	Sell	-1	Closed	–	–	2038
2018 Q3	$0	Hold	1	–	–	﹤0.01%	2704
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	2397
2018 Q1	$1K	Hold	1	–	–	﹤0.01%	2164
2017 Q4	$2K	Hold	1	–	–	﹤0.01%	1724
2017 Q3	$4K	Hold	1	–	–	﹤0.01%	1367
2017 Q2	$2K	Hold	1	–	–	﹤0.01%	1445
2017 Q1	$3K	Buy	+1	New	+$6.98K	﹤0.01%	1261

Other funds holding TOVX

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Steward Partners Investment Advisory's TOVX Position: Q3 2024 in Review

Steward Partners Investment Advisory sold out of Theriva Biologics (TOVX) in Q3 2024, closing a stake of 1 share — an estimated $3 sold.

Steward Partners Investment Advisory first reported a position in TOVX in Q1 2017 and held it in 28 quarters. The position peaked at $4K in Q3 2017. 18 funds tracked by Wall St. Rank hold TOVX as of Q3 2024.

Steward Partners Investment Advisory reported no remaining Theriva Biologics position as of Q3 2024 after selling out during the quarter.
Steward Partners Investment Advisory sold 1 Theriva Biologics share in Q3 2024, an estimated $3.
Steward Partners Investment Advisory first reported a position in Theriva Biologics in Q1 2017 and held it in 28 quarters.
Steward Partners Investment Advisory's Theriva Biologics position peaked at $4K in Q3 2017.
18 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.